Treatment Strategies in HER2+ Gastrointestinal Malignancies

This article discusses case studies and treatment strategies in HER2-postive gastrointestinal malignancies, and features insights from experts John Marshall, MD, Yelena Y Janjigian, MD, Melissa Lumish, MD, Daniel Catenacci, MD, Carolina Soto Chervin, MD, PhD, Wells Messersmith, MD, Robert Lentz, MD, Zev Wainberg, MD, and Vina Pulido Nguyen, MD. Sponsored in part by Daiichi Sankyo. Content independently developed by OncLive.